Literature DB >> 6262916

Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy.

S DiMauro, A F Miranda, S Khan, K Gitlin, R Friedman.   

Abstract

Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest control value) in a 52-year-old man with intolerance for strenuous exercise and recurrent pigmenturia since adolescence. All of the other enzymes of glycolysis had normal activities, and glycogen concentration was normal. Electrophoretic, heat lability, and mercury inhibition studies showed that the small residual activity in the patient's muscle was represented by the brain (BB) isoenzyme of phosphoglycerate mutase, suggesting a genetic defect of the M subunit which predominates in normal muscle. The prevalence of the BB isoenzyme in other tissues, including muscle culture, may explain why symptoms were confined to muscle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262916     DOI: 10.1126/science.6262916

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  Changing a limb muscle growth program into a resorption program.

Authors:  Liquan Cai; Biswajit Das; Donald D Brown
Journal:  Dev Biol       Date:  2006-12-19       Impact factor: 3.582

3.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

4.  Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells.

Authors:  Shephali Bhatnagar; Siva K Panguluri; Sanjay K Gupta; Saurabh Dahiya; Robert F Lundy; Ashok Kumar
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

5.  Myopathy with altered mitochondria due to a triosephosphate isomerase (TPI) deficiency.

Authors:  A Bardosi; S W Eber; M Hendrys; A Pekrun
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.

Authors:  I Mineo; N Kono; T Shimizu; N Hara; Y Yamada; S Sumi; K Nonaka; S Tarui
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Myopathies due to enzyme deficiencies.

Authors:  F Cornelio; S Di Donato
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

8.  The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Authors:  S Tsujino; S Shanske; S Sakoda; G Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

9.  Muscle glucose-6-phosphate dehydrogenase deficiency.

Authors:  N Bresolin; L Bet; M Moggio; G Meola; F Fortunato; G Comi; L Adobbati; L Geremia; S Pittalis; G Scarlato
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

10.  Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice.

Authors:  Siva K Panguluri; Shephali Bhatnagar; Akhilesh Kumar; John J McCarthy; Apurva K Srivastava; Nigel G Cooper; Robert F Lundy; Ashok Kumar
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.